Harvard Clinical Research Institute Initiates Comparative Effectiveness Study … – Genetic Engineering News

Harvard Clinical Research Institute Initiates Comparative Effectiveness Study
Genetic Engineering News
Tiotropium) Study, the purpose of which is to investigate whether Black patients with asthma are more likely to experience adverse outcomes as a result of long-acting beta-agonist (LABA) therapy. The BELT study was funded by a grant from the Agency for

and more »

View full post on asthma – Google News

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.